4d
Zacks Investment Research on MSNSage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
With the prospects for its Alzheimer’s drug aducanumab still up in the air, Biogen has moved to shore up its late-stage pipeline with a $3 billion licensing deal with Sage that adds drugs for ...
is bigger than the original Sage, with about twice as many seats—is a “nod” to the past, meant to “capture the same spirit” as the original location, albeit with some updates in line ...
Amalia Holguin finished with 21 points as Sage Hill rallied from an early deficit only to fall late in the state Division I girls' basketball final.
HUNTINGTON BEACH — The Sage Hill boys basketball team battled and clawed its way into the CIF-SS Division 3AA final by coming out on top in close games throughout the playoffs. But in the ...
“It’s kind of our thing,” Sage Hill coach D’Cean Bryant said. “If we don’t score, you don’t score. You just got to toughen up, you got ... the game on the line.
Will the recent positive trend continue leading up to its next earnings ... We expect an in-line return from the stock in the next few months. Sage Therapeutics is part of the Zacks Medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results